Manufacturing Chemist, 7 September 2022
12th American DDF Summit - Drug Delivery and Formulation
Streamlining end-to-end amorphous formulation development into a tablet suitable for Continuous Direct Compression
- Learn how bioavailability enhancement of Amorphous Solid Dispersions (ASDs) can vary from one to three orders of magnitude by optimizing both ASD and tablet formulations and processes
- Learn how state-of-the-art tools and methodologies can shorten time to Phase I/IND by accelerating formulation and development process
- Learn how Dispersome(R) technology, based on natural proteins derived from milk, broaden the formulation landscape enabling high drug load and high performing formulations
- Learn how ASD formulations manufactured by spray drying can be designed to be directly compressible by Continuous Tableting
- Learn more how Continuous Tableting is enabling disruptive innovations in the Pharma industry with respect to quality, scalability and improving supply chain flexibility and broadening Lifecycle Management options
At Hovione we are constantly innovating to find better and more efficient ways of doing things.
- If you are developing a novel drug formulation or improving your drug candidate, learn how the Dispersome® technology can increase drug solubility with clear benefits for patients
- If you are looking for the most advanced and accurate screening platform able to identify the most efficient and stable Amorphous Solid Dispersion formulations by Spray Drying, learn more about ASD-HIPROS
If you are interested in turning your most difficult challenge into a successful solution, schedule a meeting today to know how Hovione experts can support your project.
Find more at DDFSummit.com